Recurrent Ventricular Arrythmias in ICU
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-90
SponsorCentral Hospital, Nancy, France
About this trial
Electrical storm (ES) is a life-threatening syndrome defined by the recurrence of ventricular arrythmias.
ES is also represented by a wide spectrum of clinical situations ranging from recurrent monomorphic VT reduced by anti-tachycardia pacing (ATP) in relatively stable patients to recurrent VF in hemodynamically unstable patients.
Thus, the purpose of this study was to assess the incidence and predictors of long term mortality following hospitalization in the intensive care unit for ES, in a large retrospective multicentric study.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
None
Trial population
All patients admitted in ICU between january 2015 and june 2022
Trial design
Design model
Case-only
Time perspective
Retrospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Mortality
Time frame
at 5 yearsSecondary outcomes
1
Hospital duration
Time frame
0 to 30 day follow upLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Central Hospital, Nancy, France
Lead sponsor
Centre Hospitalier Régional Metz-Thionville
Collaborator
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: